Drug Efficacy

GLP‑1 Use Reaches 11% of U.S. Adults as New Evidence Spurs Policy and Safety Scrutiny

Large comparative studies report limited quality‑of‑life gains despite big weight losses, prompting pilot coverage programs and warnings about online and compounded access risks.